Literature DB >> 1675606

Glafenine-associated anaphylaxis as a cause of hospital admission in The Netherlands.

B H Stricker1, R R de Groot, J H Wilson.   

Abstract

In 1981 generalized anaphylaxis was registered on 166 occasions in Dutch general and academic hospitals. Clinical details of 120 of those patients revealed that in 107 anaphylaxis was either probable (n = 90) or possible (n = 17), whereas in 13 cases some other reaction than anaphylaxis had occurred. The series of confirmed cases contained 46 men and 61 women, with mean ages of 47 y and 48 y, respectively. There was a complete recovery in 102 patients and two patients died. Hypotension was present in 79 cases (74%), dyspnoea in 34 cases (32%) and a skin reaction, mainly urticaria, erythema or angioedema, was mentioned in 62 cases (58%). Most cases of anaphylaxis were drug-induced (76%), the main causes being the analgesic glafenine and contrast media. Glafenine was mentioned as the cause in 36% of all admissions for drug-induced anaphylaxis. Only 3.7% of cases had been reported to the voluntary reporting scheme of the Netherlands Centre for Monitoring of Adverse Reactions to Drugs. On the basis of reimbursement data, the risk of developing severe anaphylaxis to glafenine was estimated at 11.7-19.3-fold relative to indomethacin, and 13.4-20.2-fold relative to oral penicillins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675606     DOI: 10.1007/bf00265845

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  [Anaphylactic shock after use of glafenin].

Authors:  F Maesen; J M Mol; P J Brombacher; E J Bok; J M van de Voorden; J H Vijgen
Journal:  Ned Tijdschr Geneeskd       Date:  1976-07-24

2.  [Letter: Glaphenine-induced shock. 6 recent cases].

Authors:  J L Michaud; L Doublet
Journal:  Nouv Presse Med       Date:  1976-03-13

3.  [Anaphylaxis after the use of glafenine].

Authors:  R H Meyboom
Journal:  Ned Tijdschr Geneeskd       Date:  1976-05-22

4.  Estimability and estimation in case-referent studies.

Authors:  O Miettinen
Journal:  Am J Epidemiol       Date:  1976-02       Impact factor: 4.897

5.  [Anaphylactic accidents due to glaphenine. 5 cases].

Authors:  C Barral; M Faivre
Journal:  Nouv Presse Med       Date:  1975-11-15

6.  [Acute tubulo-interstitial nephropathy caused by glafenine poisoning].

Authors:  M Gaultier; C Bismuth; M L Efthymiou; L Morel-Maroger; A Romion
Journal:  Nouv Presse Med       Date:  1972-12-23

7.  [Evaluation of a national prospective survey on the undesirable effects of glafenine, antrafenine and floctafenine].

Authors:  G Cheymol; M Biour; M Bruneel; E Albengres; J D Hamel
Journal:  Therapie       Date:  1985 Jan-Feb       Impact factor: 2.070

Review 8.  Immediate hypersensitivity reactions to penicillin and related antibiotics.

Authors:  M E Weiss; N F Adkinson
Journal:  Clin Allergy       Date:  1988-11

Review 9.  Immediate hypersensitivity reactions to beta-lactam antibiotics.

Authors:  A Saxon; G N Beall; A S Rohr; D C Adelman
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

  9 in total
  6 in total

1.  Attitudinal survey of voluntary reporting of adverse drug reactions.

Authors:  I A Eland; K J Belton; A C van Grootheest; A P Meiners; M D Rawlins; B H Stricker
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 2.  Case-population studies in pharmacoepidemiology.

Authors:  Dolors Capellà; Consuelo Pedrós; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  The case-population study design: an analysis of its application in pharmacovigilance.

Authors:  Hélène Théophile; Joan-Ramon Laporte; Nicholas Moore; Karin-Latry Martin; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

Review 4.  [Anaphylaxis. Clinical manifestations and diagnosis].

Authors:  B Przybilla; J Ring; F Ruëff
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

5.  A population based case-cohort study of drug-induced anaphylaxis.

Authors:  M M van der Klauw; B H Stricker; R M Herings; W S Cost; H A Valkenburg; J H Wilson
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

Review 6.  Epidemiology of anaphylaxis in the United States.

Authors:  Matthew J Matasar; Alfred I Neugut
Journal:  Curr Allergy Asthma Rep       Date:  2003-01       Impact factor: 4.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.